814 results on '"Johnston, Fabian"'
Search Results
2. Adoption of an Enhanced Recovery After Surgery Protocol Increases Cost of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy and Does not Improve Outcomes
3. Cross-sectional imaging of gastric cancer: pearls, pitfalls and lessons learned from multidisciplinary conference
4. Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative
5. ASO Author Reflections: One Size Does Not Fit All—Enhanced Recovery After Surgery in CRS-HIPEC
6. Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers
7. Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS–HIPEC)
8. ASO Visual Abstract: Adoption of an Enhanced Recovery Program After the Surgery Protocol Increases the Cost of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy and Does Not Improve Outcomes
9. ASO Visual Abstract: Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Non-gynecologic Cancers
10. ASO Author Reflections: To Test or Not to Test: How Do We Decide the Optimal Site for Organoid Generation in Patients with Metastatic Disease?
11. ASO Author Reflections: Financial Toxicity and CRS-HIPEC—Is a Pound of Debt Worth an Ounce of Cure?
12. Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy
13. Minimum number of lymph nodes to maximize survival in non-metastatic appendiceal adenocarcinoma
14. Patient Experiences of Specialty Palliative Care in the Perioperative Period for Cancer Surgery
15. Primary Tumor Resection in Leiomyosarcoma Patients With Synchronous Isolated Lung Metastases: A National Cancer Database Study
16. Mortality risk prediction for primary appendiceal cancer
17. Dissemination and Implementation of a Community Health Worker Intervention for Disparities in Palliative Care (DeCIDE PC): a study protocol for a hybrid type 1 randomized controlled trial
18. Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis
19. Treatment patterns and outcomes for primary uterine leiomyosarcoma with synchronous isolated lung metastases: A National Cancer Database study of primary resection and metastasectomy
20. Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer
21. Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal Chemotherapy
22. ASO Visual Abstract: Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)
23. ASO Visual Abstract: Neighborhood Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy
24. ASO Author Reflections: Closing the Gap: A Call to Action to Improve Access and Outcomes of Peritoneal Surface Malignancy Care
25. Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
26. Palliative Therapies in Metastatic Pancreatic Cancer: Does Medicaid Expansion Make a Difference?
27. Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal Cancer
28. Absolute Iron Deficiency Anemia Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
29. A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC
30. Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative
31. Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study
32. Fragmentation of Care in Pancreatic Cancer: Effects on Receipt of Care and Survival
33. ASO Visual Abstract: Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy—A Multi-institutional Analysis
34. Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative
35. Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review.
36. The Perioperative and Operative Management of Esophageal and Gastric Cancer
37. Good Bone Structure: A Call for Stronger Design and Methodology in Disparities Studies in Orthopedic Oncology
38. Implementation Barriers and Recommendations for a Multisite Community Health Worker Intervention in Palliative Care for African American Oncology Patients: A Qualitative Study
39. Disparities in Access to Oncologic Care in Pancreatic Cancer: A Systematic Review
40. Bias Issues in Colorectal Cancer Management: A Review
41. Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care
42. Surgeon-reported Factors Influencing Adoption of Quality Standards for Goal-concordant Care in Patients With Advanced Cancer: A Qualitative Study
43. Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC Collaborative
44. Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database
45. ASO Visual Abstract: Conditional Survival After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
46. Barriers to Equitable Palliative Care Utilization Among Patients with Cancer
47. ASO Author Reflections: Disparities in Receipt of Palliative Therapies for Pancreatic Cancer: Did Medicaid Expansion Help?
48. ASO Visual Abstract: Palliative Therapies in Metastatic Pancreatic Cancer—Does Medicaid Expansion Make a Difference?
49. The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative
50. Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.